New Jersey Senate Bill S1521

New Jersey 2022-2023 Regular Session

• Introduced: 2/10/22
• Refer: 2/10/22

Caption

Requires health care professionals to order bi-lateral ultrasounds concurrently when ordering mammograms; requires insurers to cover concurrent mammograms and bilateral ultrasounds.

Impact

The legislation, upon enactment, amends existing laws regarding health coverage for mammograms and associated procedures. This change is expected to significantly enhance women's health services by making it mandatory for insurance providers to include coverage for ultrasounds and other imaging tests when ordered alongside standard mammograms. The requirement applies to all contracts and health policies approved by the New Jersey Commissioner of Banking and Insurance, which broadens healthcare access and aims to support women who face higher risks of breast cancer.

Summary

Senate Bill S1521 is aimed at improving the diagnostic protocols for breast cancer in New Jersey by requiring healthcare providers to order bilateral ultrasounds concurrently with mammograms for patients who have additional risk factors for breast cancer. This requirement extends to situations where the mammogram results are suspicious or indicative of dense breast tissue, ensuring that women receive comprehensive evaluations that may facilitate earlier detection of cancer. The bill also mandates that health insurers cover these additional testing requirements, ensuring that financial barriers do not inhibit access to critical diagnostic procedures.

Contention

While the bill is supported by many healthcare advocates for its potential positive impact on women's health, there may be concerns from insurance companies regarding the increased costs associated with expanded coverage for additional testing. Stakeholders are expected to discuss the implications this might have on premiums and insurance policy structures. Additionally, debates may arise over the appropriateness of mandating extra testing for certain demographics, particularly as it applies to women of color who are explicitly mentioned in the legislation. This could lead to discussions about equity in health services and the need for tailored approaches based on individual risk factors.